TECH
Bio-Techne Corporation NASDAQ Listed Feb 9, 1989$50.91
Mkt Cap $8.0B
52w Low $45.12
21.4% of range
52w High $72.16
50d MA $54.53
200d MA $58.15
P/E (TTM)
117.1x
EV/EBITDA
38.7x
P/B
4.5x
Debt/Equity
0.2x
ROE
3.8%
P/FCF
31.6x
RSI (14)
—
ATR (14)
—
Beta
1.49
50d MA
$54.53
200d MA
$58.15
Avg Volume
2.3M
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
614 McKinley Place N.E. · Minneapolis, MN 55413 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | TNS | 0.55 | 0.53 | -3.6% | 47.41 | -0.4% | +7.4% | — | — | — | — | — |
| Feb 4, 2026 | TNS | 0.43 | 0.46 | +7.0% | 68.67 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% | — |
| Nov 5, 2025 | TNS | 0.42 | 0.42 | -0.3% | 59.94 | +0.8% | -2.9% | -1.3% | +0.1% | +3.0% | +3.8% | — |
| Aug 6, 2025 | TNS | 0.50 | 0.53 | +6.1% | 49.87 | +1.3% | +0.6% | +0.5% | -0.5% | +5.3% | +3.6% | — |
| May 7, 2025 | TNS | 0.51 | 0.56 | +10.2% | 48.75 | -0.3% | +2.1% | +0.3% | +7.9% | -4.2% | -7.3% | — |
| Feb 5, 2025 | TNS | 0.39 | 0.42 | +8.8% | 75.25 | +2.4% | -0.3% | -2.9% | -4.0% | -2.3% | -1.3% | — |
| Oct 30, 2024 | TNS | 0.38 | 0.42 | +10.5% | 76.02 | -0.2% | -3.0% | +2.1% | +0.8% | +2.3% | -2.3% | — |
| Aug 7, 2024 | TNS | 0.49 | 0.49 | -1.0% | 70.96 | +1.3% | +3.4% | -2.2% | +0.0% | +2.3% | -1.0% | — |
| May 1, 2024 | TNS | 0.45 | 0.48 | +6.0% | 73.46 | +1.3% | +2.9% | +2.2% | -1.6% | +1.8% | -0.5% | — |
| Feb 1, 2024 | TNS | 0.41 | 0.40 | -3.0% | 68.54 | -2.7% | -3.7% | +1.2% | +0.9% | -1.5% | +2.4% | — |
| Oct 31, 2023 | TNS | 0.44 | 0.41 | -6.8% | 54.63 | +0.5% | -3.3% | +4.9% | +6.0% | -0.1% | +1.6% | — |
| Aug 8, 2023 | TNS | 0.55 | 0.55 | +0.0% | 84.30 | -0.1% | -1.5% | +0.0% | +1.7% | +0.5% | -0.2% | — |
| May 3, 2023 | BMO | 0.53 | 0.53 | +0.0% | 85.98 | -0.2% | -2.3% | -1.1% | -1.0% | -1.4% | +0.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6 | Evercore ISI | Maintains | In Line → In Line | — | $53.13 | $53.13 | +0.0% | +1.3% | +0.1% | +2.6% | +0.7% | -0.1% |
| Feb 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $65.86 | $66.76 | +1.4% | +1.4% | -1.9% | -1.0% | -2.1% | -6.2% |
| Feb 5 | UBS | Maintains | Buy → Buy | — | $68.67 | $68.04 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% |
| Feb 5 | TD Cowen | Maintains | Buy → Buy | — | $68.67 | $68.04 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% |
| Feb 5 | Evercore ISI | Maintains | In Line → In Line | — | $68.67 | $68.04 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% |
| Feb 5 | Stifel | Maintains | Hold → Hold | — | $68.67 | $68.04 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% |
| Feb 5 | Citigroup | Maintains | Buy → Buy | — | $68.67 | $68.04 | -0.9% | -4.1% | +1.4% | -1.9% | -1.0% | -2.1% |
| Jan 5 | Evercore ISI | Downgrade | Outperform → In Line | — | $59.65 | $59.05 | -1.0% | +5.7% | +3.6% | -0.4% | -0.7% | +1.7% |
| Nov 20 | Argus | Maintains | Buy → Buy | — | $57.81 | $59.10 | +2.2% | +1.6% | +4.8% | +3.2% | +3.7% | -1.9% |
| Nov 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $59.94 | $60.43 | +0.8% | -2.9% | -1.3% | +0.1% | +3.0% | +3.8% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $59.94 | $60.43 | +0.8% | -2.9% | -1.3% | +0.1% | +3.0% | +3.8% |
| Oct 14 | TD Cowen | Maintains | Buy → Buy | — | $59.65 | $58.73 | -1.5% | -0.6% | +0.5% | +3.4% | +0.4% | +1.1% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $61.92 | $62.10 | +0.3% | -4.4% | +2.3% | -1.1% | -2.1% | +1.7% |
| Sep 3 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $53.42 | $53.60 | +0.3% | -0.1% | -0.8% | +2.8% | -0.6% | +0.2% |
| Aug 21 | Citigroup | Upgrade | Neutral → Buy | — | $54.33 | $54.66 | +0.6% | -0.6% | +5.7% | -0.7% | +0.1% | -1.0% |
| Aug 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $49.87 | $50.51 | +1.3% | +0.6% | +0.5% | -0.5% | +5.3% | +3.6% |
| Jul 11 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $54.41 | $53.68 | -1.3% | -0.5% | -2.8% | -2.3% | +0.7% | +2.9% |
| Jun 5 | Benchmark | Maintains | Buy → Buy | — | $49.85 | $49.80 | -0.1% | -3.1% | +0.8% | +2.4% | +3.0% | +0.3% |
| May 9 | UBS | Maintains | Buy → Buy | — | $49.78 | $50.00 | +0.4% | +0.3% | +7.9% | -4.2% | -7.3% | +0.8% |
| May 8 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $48.75 | $48.59 | -0.3% | +2.1% | +0.3% | +7.9% | -4.2% | -7.3% |
| May 8 | Benchmark | Maintains | Buy → Buy | — | $48.75 | $48.59 | -0.3% | +2.1% | +0.3% | +7.9% | -4.2% | -7.3% |
| May 8 | Stifel | Maintains | Hold → Hold | — | $48.75 | $48.59 | -0.3% | +2.1% | +0.3% | +7.9% | -4.2% | -7.3% |
| Apr 9 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $48.81 | $46.53 | -4.7% | +10.8% | -8.9% | +3.0% | +3.6% | -2.8% |
| Apr 8 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $52.31 | $53.26 | +1.8% | -6.7% | +10.8% | -8.9% | +3.0% | +3.6% |
| Mar 4 | Citigroup | Maintains | Neutral → Neutral | — | $61.19 | $60.70 | -0.8% | -1.7% | +3.5% | +1.9% | +1.5% | -2.3% |
| Feb 19 | Baird | Downgrade | Outperform → Neutral | — | $65.29 | $63.52 | -2.7% | +0.8% | -0.5% | -0.9% | +1.0% | -2.0% |
| Feb 6 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $75.25 | $77.03 | +2.4% | -0.3% | -2.9% | -4.0% | -2.3% | -1.3% |
| Feb 6 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $75.25 | $77.03 | +2.4% | -0.3% | -2.9% | -4.0% | -2.3% | -1.3% |
| Feb 6 | Baird | Maintains | Outperform → Outperform | — | $75.25 | $77.03 | +2.4% | -0.3% | -2.9% | -4.0% | -2.3% | -1.3% |
| Feb 6 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $75.25 | $77.03 | +2.4% | -0.3% | -2.9% | -4.0% | -2.3% | -1.3% |
| Oct 31 | Baird | Maintains | Outperform → Outperform | — | $76.02 | $75.89 | -0.2% | -3.0% | +2.1% | +0.8% | +2.3% | -2.3% |
| Oct 31 | Scotiabank | Maintains | Sector Outperform → Sector Outperform | — | $76.02 | $75.89 | -0.2% | -3.0% | +2.1% | +0.8% | +2.3% | -2.3% |
| Aug 13 | Benchmark | Maintains | Buy → Buy | — | $71.78 | $71.65 | -0.2% | +2.3% | -1.0% | +3.0% | -0.5% | +0.6% |
| Aug 8 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $70.96 | $71.90 | +1.3% | +3.4% | -2.2% | +0.0% | +2.3% | -1.0% |
| Aug 8 | Baird | Maintains | Outperform → Outperform | — | $70.96 | $71.90 | +1.3% | +3.4% | -2.2% | +0.0% | +2.3% | -1.0% |
| May 22 | Citigroup | Downgrade | Buy → Neutral | — | $82.68 | $80.97 | -2.1% | +0.4% | -3.1% | +0.5% | -1.7% | -1.0% |
| May 2 | Baird | Maintains | Outperform → Outperform | — | $73.46 | $74.45 | +1.3% | +2.9% | +2.2% | -1.6% | +1.8% | -0.5% |
| May 2 | Benchmark | Maintains | Buy → Buy | — | $73.46 | $74.45 | +1.3% | +2.9% | +2.2% | -1.6% | +1.8% | -0.5% |
| Apr 18 | Deutsche Bank | Maintains | Buy → Buy | — | $62.73 | $61.61 | -1.8% | -0.8% | -0.1% | +1.1% | +1.4% | -0.3% |
| Feb 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $68.54 | $66.68 | -2.7% | -3.7% | +1.2% | +0.9% | -1.5% | +2.4% |
| Feb 2 | Stifel | Downgrade | Buy → Hold | — | $68.54 | $66.68 | -2.7% | -3.7% | +1.2% | +0.9% | -1.5% | +2.4% |
| Feb 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $68.54 | $66.68 | -2.7% | -3.7% | +1.2% | +0.9% | -1.5% | +2.4% |
| Nov 2 | Stifel | Maintains | Buy → Buy | — | $52.83 | $53.77 | +1.8% | +4.9% | +6.0% | -0.1% | +1.6% | -1.6% |
| Nov 1 | Citigroup | Maintains | Buy → Buy | — | $54.63 | $54.93 | +0.5% | -3.3% | +4.9% | +6.0% | -0.1% | +1.6% |
| Nov 1 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $54.63 | $54.93 | +0.5% | -3.3% | +4.9% | +6.0% | -0.1% | +1.6% |
| Nov 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $54.63 | $54.93 | +0.5% | -3.3% | +4.9% | +6.0% | -0.1% | +1.6% |
| Sep 12 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $71.63 | $71.21 | -0.6% | +0.5% | +0.7% | +2.1% | -0.5% | -3.4% |
| Aug 18 | Benchmark | Maintains | Buy → Buy | — | $80.24 | $79.59 | -0.8% | -2.5% | +0.6% | -0.6% | +0.6% | +0.1% |
| Aug 9 | Stephens & Co. | Maintains | Overweight → Overweight | — | $84.30 | $84.20 | -0.1% | -1.5% | +0.0% | +1.7% | +0.5% | -0.2% |
| May 4 | Stephens & Co. | Maintains | Overweight → Overweight | — | $85.98 | $85.83 | -0.2% | -2.3% | -1.1% | -1.0% | -1.4% | +0.1% |
No insider trades available.
8-K · 2.02
!! High
Bio-Techne Corporation -- 8-K 2.02: Earnings Results
Bio-Techne Corporation reported Q2 2026 earnings results for the quarter and nine months ended March 31, 2026, disclosing operational performance and financial condition metrics to shareholders.
May 6
8-K · 5.02
!!! Very High
Bio-Techne Corp. -- 8-K 5.02: Executive Change
Bio-Techne's Diagnostics and Spatial Biology segment President Matt McManus is departing March 1, 2026, though he'll remain temporarily to ensure transition continuity.
Feb 11
8-K · 8.01
!! High
Bio-Techne Corp. -- 8-K 8.01: Material Event / Announcement
Bio-Techne Corporation announced a cash dividend, signaling confidence in its financial position and returning capital to shareholders.
Feb 4
Data updated apr 27, 2026 4:22am
· Source: massive.com